High-dose aspirin, nonsteroidal anti-inflammatory drugs, and methylprednisolone, as well as specific TNF-α antagonists and other anti-RA and anti-inflammatory drugs, can activate the RANKL/OPG pathway to protect bone tissue and effectively alleviate inflammation. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.